Modifications etc. (not altering text)
C1Sch. 9A applied in part (with modifications) (31.12.2004) by The Insurance Accounts Directive (Lloyd's Syndicate and Aggregate Accounts) Regulations 2004 (S.I. 2004/3219), reg. 3(4)(d), Sch.
Sch. 9A applied in part (31.12.2004) by The Insurance Accounts Directive (Lloyd's Syndicate and Aggregate Accounts) Regulations 2004 (S.I. 2004/3219), reg. 8(4)(5)
Valid from 12/11/2004
65A(1)This paragraph applies where financial instruments have been valued in accordance with paragraph 29A or 29C.
(2)The items affected and the basis of valuation adopted in determining the amounts of the financial instruments must be disclosed.
(3)The purchase price of the financial instruments must be disclosed.
(4)There must be stated–
(a)where the fair value of the instruments has been determined in accordance with paragraph 29B(4), the significant assumptions underlying the valuation models and techniques used,
(b)for each category of financial instrument, the fair value of the instruments in that category and the changes in value–
(i)included in the profit and loss account, or
(ii)credited to or (as the case may be) debited from the fair value reserve,
in respect of those instruments, and
(c)for each class of derivatives, the extent and nature of the instruments, including significant terms and conditions that may affect the amount, timing and certainty of future cash flows.
(5)Where any amount is transferred to or from the fair value reserve during the financial year, there must be stated in tabular form–
(a)the amount of the reserve as at the date of the beginning of the financial year and as at the balance sheet date respectively;
(b)the amount transferred to or from the reserve during that year; and
(c)the source and application respectively of the amounts so transferred.